Thank you very much. Your time is up.
We are going to take around five minutes off the end of the next round, so I'm going to take a chairman's privilege and ask a short question. This one may go to, I think, Mr. Emmott.
I was interested because I was in dairy. It just astounds me, the increase in production. As we know, genetics doesn't just increase the production, because you have to build the body around that. When we're talking about the research—and this may be a question for Semex when the time comes, also—I'm wondering about the time for and the significance of developing those genetic upgrades, not only for milk production, but there's feet and legs and all those things that go with it. I might just save that for Semex.
You mentioned CETA. A question was asked about whether there is funding in place. I think, clearly, the agreement talks about.... That follows, as you mentioned, the five to seven, or ten years after....
I'm interested in getting a bit of a handle on the amount of dollars that have been going into the research that would actually turn into the innovation part. I like the definition Jim gave us for clarity of understanding. Has that changed? Now it is not just about the European market. I think, Bill, what it is about is that this research and innovation part—particularly now the research—is the relationship with the processors, as the part of that cluster to develop the research. What is happening with the amount of dollars that would be going into that, and with being able to develop the Canadian cheeses that would meet the satisfaction of what we continually talk about, our domestic market and the local market, which is clearly a Canadian market? How is that working to come together? Do you have any of those numbers of potential increase in the budget, as to what has been in the budget for that type of research?